Scott Gottlieb is skeptical of the science behind CBD supplements
An insider's guide to the politics and policy of health care.
D.C. Diagnosis is STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.
Scott Gottlieb has a lot of thoughts on CBD
When I chatted with the former FDA commissioner about the agency’s efforts to regulate CBD, one thing was crystal clear: Gottlieb probably isn’t going to be offered a job as the head of the CBD lobby any time soon.
“There’s no science to demonstrate that putting it in the
